CRSP
CRISPR Therapeutics AG ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
CRISPR Therapeutics AG (CRSP) is held by 4 tracked hedge fund(s). Largest tracked holder: ARK Investment Management LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ARK Investment Management LLC ARK Investment Management LLC |
4.2% | 11.3M | $538M | ▲ 7.5% (+792K) | $45.78 | 2026-03-31 |
| Orbis Allan Gray Ltd Orbis Allan Gray Ltd |
1.2% | 6.1M | $290M | ▲ 2.6% (+156K) | $52.64 | 2026-03-31 |
| Amova Asset Management Americas, Inc. Amova Asset Management Americas, Inc. |
1.2% | 1.9M | $88M | ▼ 5.3% (−104K) | $45.23 | 2026-03-31 |
| Contrarius Investment Stephen Mildenhall |
2.1% | 784K | $37M | ▲ 14% (+98K) | $62.35 | 2024-09-30 |
Related ▾
FAQ ▾
Which hedge funds hold CRSP?
Tracked holders include: ARK Investment Management LLC, Orbis Allan Gray Ltd, Amova Asset Management Americas, Inc., Contrarius Investment.
How much smart money owns CRSP?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading CRSP?
No tracked Congressional trades in CRSP on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.